Alchemab Therapeutics Ltd
Alchemab Therapeutics Ltd is a biotechnology company that discovers and develops therapeutic antibodies by mining human immune repertoires and identifying naturally occurring, disease-protective immune responses. The company combines systems immunology, computational analysis, and experimental validation to translate protective antibody signatures into diagnostic tools and monoclonal antibody therapeutics across multiple disease areas.
Leadership & Board
Key Executives
- Founder
- Jane Osbourn OBE
- Founder
- Rachael Bashford-Rogers
- Current Number of Employees
- 75
- Current LinkedIn Followers
- 12,262
Latest Estimated Valuation
- Estimated Valuation
- ―
- Total Amount Raised
- $65M
- Total Funding Rounds
- 2
- Latest Funding Amount
- $33M
- Latest Funding Round
- Series A
- Post-Money Valuation
- ―
Employee Trend
Alchemab Therapeutics Ltd had 75 employees as of October 12, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Alchemab Therapeutics Ltd had 12,262 followers as of October 12, 2026. The number of followers increased by 27 (0.22%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Jul 15, 2026 | Series A | $33.00M | ― |
| Oct 09, 2025 | Series A | $32.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Ono Venture Investment | Series A |
Similar Companies
A snapshot of private companies similar to Alchemab Therapeutics Ltd, helping you discover and navigate related company profiles.
Related News and Analysis
